<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340756</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2197-425X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Intensive care medicine experimental</Title><ISOAbbreviation>Intensive Care Med Exp</ISOAbbreviation></Journal><ArticleTitle>Association of corticosteroid therapy with reduced acute kidney injury and lower NET markers in severe COVID-19: an observational study.</ArticleTitle><Pagination><StartPage>85</StartPage><MedlinePgn>85</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">85</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40635-024-00670-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common in critical cases of coronavirus disease 2019 (COVID-19) and associated with worse outcome. Dysregulated neutrophil extracellular trap (NET) formation is one of several suggested pathophysiological mechanisms involved in the development of COVID-19 associated AKI. The corticosteroid dexamethasone was implemented as a standard treatment for severe COVID-19 as of June 2020. A sub-analysis of a prospective observational single center study was performed to evaluate the effect of corticosteroid treatment on AKI development and NET markers in critical cases of COVID-19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred and ten adult patients admitted to intensive care at a tertiary level hospital due to respiratory failure or shock secondary to SARS-CoV-2-infection between March 13th 2020 and January 14th 2021 were included in the study. Ninety-seven of those did not receive corticosteroids. One hundred and thirteen patients were treated with corticosteroids [dexamethasone (n = 98) or equivalent treatment (n = 15)], but the incidence of AKI was assessed only in patients that received corticosteroids before any registered renal dysfunction (n = 63). Corticosteroids were associated with a lower incidence of AKI (19% vs 55.8%, p &lt; 0.001). Fewer patients demonstrated detectable concentrations of extracellular histones in plasma when treated with corticosteroids (8.7% vs 43.1%; p &lt; 0.001). Extracellular histones and in particular non-proteolyzed histones were observed more frequently with increasing AKI severity (p &lt; 0.001). MPO-DNA was found in lower concentrations in patients that received corticosteroids before established renal dysfunction (p = 0.03) and was found in higher concentrations in patients with AKI stage 3 (p = 0.03). Corticosteroids did not ameliorate established AKI during the first week of treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Corticosteroid treatment in severe COVID-19 is associated with a lower incidence of AKI and reduced concentrations of NET markers in plasma.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bülow Anderberg</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8769-7036</Identifier><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, 751 85, Uppsala, Sweden. sara.bulow@uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huckriede</LastName><ForeName>Joram</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hultström</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, 751 85, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Cell Biology, Integrative Physiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Femke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipcsey</LastName><ForeName>Miklos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, 751 85, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolaes</LastName><ForeName>Gerry A F</ForeName><Initials>GAF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, 751 85, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Uppsala Centre for Paediatric Anesthesia and Intensive Care Research, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KAW 2020.0182</GrantID><Agency>Science for Life Laboratory</Agency><Country /></Grant><Grant><GrantID>KAW 2020.0241</GrantID><Agency>Science for Life Laboratory</Agency><Country /></Grant><Grant><GrantID>20210089</GrantID><Agency>Hjärt-Lungfonden</Agency><Country /></Grant><Grant><GrantID>2014-02569</GrantID><Agency>Vetenskapsrådet</Agency><Country /></Grant><Grant><GrantID>2014-07606</GrantID><Agency>Vetenskapsrådet</Agency><Country /></Grant><Grant><GrantID>F2020-0054</GrantID><Agency>Svensk Njurmedicinsk Förening</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Intensive Care Med Exp</MedlineTA><NlmUniqueID>101645149</NlmUniqueID><ISSNLinking>2197-425X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Corticosteroids</Keyword><Keyword MajorTopicYN="N">Histones</Keyword><Keyword MajorTopicYN="N">MPO-DNA</Keyword><Keyword MajorTopicYN="N">NETs</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340756</ArticleId><ArticleId IdType="pmc">PMC11438749</ArticleId><ArticleId IdType="doi">10.1186/s40635-024-00670-3</ArticleId><ArticleId IdType="pii">10.1186/s40635-024-00670-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179–c184</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver SA, Beaubien-Souligny W, Shah PS, Harel S, Blum D, Kishibe T, Meraz-Munoz A, Wald R, Harel Z (2021) The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis. Kidney Med 3:83-98.e81</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723763</ArticleId><ArticleId IdType="pubmed">33319190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultström M, Lipcsey M, Wallin E, Larsson IM, Larsson A, Frithiof R (2021) Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care 25:37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7829656</ArticleId><ArticleId IdType="pubmed">33494766</ArticleId></ArticleIdList></Reference><Reference><Citation>Luther T, Bülow-Anderberg S, Larsson A, Rubertsson S, Lipcsey M, Frithiof R, Hultström M (2021) COVID-19 patients in intensive care develop predominantly oliguric acute kidney injury. Acta Anaesthesiol Scand 65:364–372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753792</ArticleId><ArticleId IdType="pubmed">33190222</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V (2021) Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 17:751–764</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>Luther T, Eckerbom P, Cox E, Lipcsey M, Bülow S, Hultström M, Torrente FM, Weis J, Palm F, Francis S, Frithiof R, Liss P (2022) Decreased renal perfusion during acute kidney injury in critical COVID-19 assessed by magnetic resonance imaging: a prospective case control study. Crit Care 26:262</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9434518</ArticleId><ArticleId IdType="pubmed">36050748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bülow Anderberg S, Luther T, Berglund M, Larsson R, Rubertsson S, Lipcsey M, Larsson A, Frithiof R, Hultström M (2021) Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients. Cytokine 138:155389</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833204</ArticleId><ArticleId IdType="pubmed">33348065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M (2022) Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: a prospective observational study. Cytokine 149:155727</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491926</ArticleId><ArticleId IdType="pubmed">34628127</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535</Citation><ArticleIdList><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, Schneider AH, Caetité D, Tavares LA, Paiva IM, Rosales R, Colón D, Martins R, Castro IA, Almeida GM, Lopes MIF, Benatti MN, Bonjorno LP, Giannini MC, Luppino-Assad R, Almeida SL, Vilar F, Santana R, Bollela VR, Auxiliadora-Martins M, Borges M, Miranda CH, Pazin-Filho A, da Silva LLP, Cunha LD, Zamboni DS, Dal-Pizzol F, Leiria LO, Siyuan L, Batah S, Fabro A, Mauad T, Dolhnikoff M, Duarte-Neto A, Saldiva P, Cunha TM, Alves-Filho JC, Arruda E, Louzada-Junior P, Oliveira RD, Cunha FQ (2020) SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med 217:e20201129</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488868</ArticleId><ArticleId IdType="pubmed">32926098</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries F, Huckriede J, Wichapong K, Reutelingsperger C, Nicolaes GAF (2023) The role of extracellular histones in COVID-19. J Intern Med 293:275–292</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10108027</ArticleId><ArticleId IdType="pubmed">36382685</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D, Marschner JA, Platen L, Anders HJ (2018) Extracellular traps in kidney disease. Kidney Int 94:1087–1098</Citation><ArticleIdList><ArticleId IdType="pubmed">30466565</ArticleId></ArticleIdList></Reference><Reference><Citation>Huckriede J, de Vries F, Hultström M, Wichapong K, Reutelingsperger C, Lipcsey M, Garcia de Frutos P, Frithiof R, Nicolaes GAF (2021) Histone H3 cleavage in severe COVID-19 ICU patients. Front Cell Infect Microbiol 11:694186</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461091</ArticleId><ArticleId IdType="pubmed">34568088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekaney ML, Otto GP, Sossdorf M, Sponholz C, Boehringer M, Loesche W, Rittirsch D, Wilharm A, Kurzai O, Bauer M, Claus RA (2014) Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care 18:543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201918</ArticleId><ArticleId IdType="pubmed">25260379</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li Y, Sun N, Tang H, Ye J, Liu Y, He Q, Fu Y, Zhu H, Jiang C, Xu J (2022) NETosis is critical in patients with severe community-acquired pneumonia. Front Immunol 13:1051140</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709478</ArticleId><ArticleId IdType="pubmed">36466920</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch MH, Timmermans S, Nagy M, Visser M, Huckriede J, Aendekerk JP, de Vries F, Potjewijd J, Jallah B, Ysermans R, Oude Lashof AML, Breedveld PH, van de Poll MCG, van de Horst ICC, van Bussel BCT, Theunissen R, Spronk HMH, Damoiseaux J, Ten Cate H, Nicolaes GAF, Reutelingsperger CP, van Paassen P (2020) Neutrophils and contact activation of coagulation as potential drivers of COVID-19. Circulation 142:1787–1790</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594534</ArticleId><ArticleId IdType="pubmed">32946302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim IS, Kim DH, Lee HW, Kim SG, Kim YK, Kim JK (2023) Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients. Front Immunol 14:1122510</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083414</ArticleId><ArticleId IdType="pubmed">37051234</ArticleId></ArticleIdList></Reference><Reference><Citation>Silk E, Zhao H, Weng H, Ma D (2017) The role of extracellular histone in organ injury. Cell Death Dis 8:e2812</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520745</ArticleId><ArticleId IdType="pubmed">28542146</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with covid-19. N Engl J Med 384:693–704</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyman U, Grubb A, Larsson A, Hansson LO, Flodin M, Nordin G, Lindström V, Björk J (2014) The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med 52:815–824</Citation><ArticleIdList><ArticleId IdType="pubmed">24334413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildhagen KC, Wiewel MA, Schultz MJ, Horn J, Schrijver R, Reutelingsperger CP, van der Poll T, Nicolaes GA (2015) Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients. Thromb Res 136:542–547</Citation><ArticleIdList><ArticleId IdType="pubmed">26232351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z, Abrams ST, Alhamdi Y, Toh J, Yu W, Wang G, Toh CH (2019) Circulating histones are major mediators of multiple organ dysfunction syndrome in acute critical illnesses. Crit Care Med 47:e677–e684</Citation><ArticleIdList><ArticleId IdType="pubmed">31162199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano H, Aminul Huq M, Tsuda M, Noguchi H, Takeyama N (2017) Sandwich ELISA for circulating myeloperoxidase- and neutrophil elastase-DNA complexes released from neutrophil extracellular traps. Adv Tech Biol Med 05:e1000196</Citation></Reference><Reference><Citation>Leest PV, Boonstra PA, Elst AT, Kempen LCV, Tibbesma M, Koopmans J, Miedema A, Tamminga M, Groen HJM, Reyners AKL, Schuuring E (2020) Comparison of circulating cell-free DNA extraction methods for downstream analysis in cancer patients. Cancers (Basel) 12:e1222</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281769</ArticleId><ArticleId IdType="pubmed">32414097</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9:30</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765115</ArticleId><ArticleId IdType="pubmed">23947590</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda S, Nakazawa D, Shida H, Miyoshi A, Kusunoki Y, Tomaru U, Ishizu A (2016) NETosis markers: quest for specific, objective, and quantitative markers. Clin Chim Acta 459:89–93</Citation><ArticleIdList><ArticleId IdType="pubmed">27259468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuperminc E, Heming N, Carlos M, Annane D (2023) Corticosteroids in ARDS. J Clin Med 12:3340</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10179626</ArticleId><ArticleId IdType="pubmed">37176780</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Forni LG, Klein SJ, Honore PM, Kashani K, Ostermann M, Prowle J, Bagshaw SM, Cantaluppi V, Darmon M, Ding X, Fuhrmann V, Hoste E, Husain-Syed F, Lubnow M, Maggiorini M, Meersch M, Murray PT, Ricci Z, Singbartl K, Staudinger T, Welte T, Ronco C, Kellum JA (2020) Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med 46:654–672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103017</ArticleId><ArticleId IdType="pubmed">31820034</ArticleId></ArticleIdList></Reference><Reference><Citation>Frithiof R, Bergqvist A, Järhult JD, Lipcsey M, Hultström M (2020) Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients. Crit Care 24:587</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523248</ArticleId><ArticleId IdType="pubmed">32993742</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannes T, Mik EG, Klingel K, Dieterich H-J, Unertl KE, Ince C (2009) Low-dose dexamethasone-supplemented fluid resuscitation reverses endotoxin-induced acute renal failure and prevents cortical microvascular hypoxia. Shock 31:521</Citation><ArticleIdList><ArticleId IdType="pubmed">18827749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao CM, Ho ST, Chen A, Wang JJ, Li CY, Tsai SK, Wu CC (2004) Low-dose dexamethasone ameliorates circulatory failure and renal dysfunction in conscious rats with endotoxemia. Shock 21:484–491</Citation><ArticleIdList><ArticleId IdType="pubmed">15087827</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Chan MTV, Cuerden MS, Devereaux PJ, Abbasi SH, Hildebrand A, Lamontagne F, Lamy A, Noiseux N, Parikh CR, Perkovic V, Quantz M, Rochon A, Royse A, Sessler DI, Shah PJ, Sontrop JM, Tagarakis GI, Teoh KH, Vincent J, Walsh M, Yared JP, Yusuf S, Whitlock RP (2019) Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial. CMAJ 191:E247-e256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6400656</ArticleId><ArticleId IdType="pubmed">30833491</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS (2015) Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol 26:2947–2951</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference><Reference><Citation>Orieux A, Khan P, Prevel R, Gruson D, Rubin S, Boyer A (2021) Impact of dexamethasone use to prevent from severe COVID-19-induced acute kidney injury. Crit Care 25:249</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283744</ArticleId><ArticleId IdType="pubmed">34271956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobot M, Tonon D, Peres N, Guervilly C, Lefèvre F, Max H, Bommel Y, Volff M, Leone M, Lopez A, Simeone P, Carvelli J, Chopinet S, Hraiech S, Papazian L, Velly L, Bourenne J, Forel JM (2022) Impact of dexamethasone and inhaled nitric oxide on severe acute kidney injury in critically ill patients with COVID-19. J Clin Med 11:6130</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9604787</ArticleId><ArticleId IdType="pubmed">36294451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658</Citation><ArticleIdList><ArticleId IdType="pubmed">3306374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A (2010) Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci 107:9813–9818</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2906830</ArticleId><ArticleId IdType="pubmed">20439745</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Ruiz J, Villca-Gonzales R, Gómez-Martín D, Zentella-Dehesa A, Tapia-Rodríguez M, Uribe-Uribe NO, Morales-Buenrostro LE, Alberú J (2020) A potential role of neutrophil extracellular traps (NETs) in kidney acute antibody mediated rejection. Transpl Immunol 60:101286</Citation><ArticleIdList><ArticleId IdType="pubmed">32156665</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Gao T, Zhang R, Hu J, Gao S, Wang Y, Qi X, Zhou Y, Zheng G, Dong H (2023) Neutrophil extracellular traps aggravate contrast-induced acute kidney injury by damaging glomeruli and peritubular capillaries. J Inflamm Res 16:5629–5646</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10693253</ArticleId><ArticleId IdType="pubmed">38046404</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT (2009) Extracellular histones are major mediators of death in sepsis. Nat Med 15:1318–1321</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2783754</ArticleId><ArticleId IdType="pubmed">19855397</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaikoski PG, Mota JMSC, Nascimento DC, Sônego F, Castanheira FVS, Melo PH, Scortegagna GT, Silva RL, Barroso-Sousa R, Souto FO, Pazin-Filho A, Figueiredo F, Alves-Filho JC, Cunha FQ (2016) Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS ONE 11:e0148142</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743982</ArticleId><ArticleId IdType="pubmed">26849138</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, Stürzl M, Staats L, Mahajan A, Schauer C, Kremer AN, Völkl S, Amann K, Evert K, Falkeis C, Wehrfritz A, Rieker RJ, Hartmann A, Kremer AE, Neurath MF, Muñoz LE, Schett G, Herrmann M (2020) Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine 58:102925</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397705</ArticleId><ArticleId IdType="pubmed">32745993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi F, Giaglis S, Hahn S, Blum CA, Baumgartner C, Kutz A, van Breda SV, Mueller B, Schuetz P, Christ-Crain M, Hasler P (2018) Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial. Eur Respir J 51:1701389</Citation><ArticleIdList><ArticleId IdType="pubmed">29519921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan T, Zhao Y, Fan F, Hu R, Jin X (2017) Dexamethasone inhibits S. aureus-induced neutrophil extracellular pathogen-killing mechanism, possibly through toll-like receptor regulation. Front Immunol 8:60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5299007</ArticleId><ArticleId IdType="pubmed">28232829</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechamps M, De Poortere J, Octave M, Ginion A, Robaux V, Pirotton L, Bodart J, Gruson D, Van Dievoet MA, Douxfils J, Haguet H, Morimont L, Derive M, Jolly L, Bertrand L, Laterre PF, Horman S, Beauloye C (2023) Dexamethasone modulates the cytokine response but not COVID-19-induced coagulopathy in critically ill. Int J Mol Sci 24:7278</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10138864</ArticleId><ArticleId IdType="pubmed">37108440</ArticleId></ArticleIdList></Reference><Reference><Citation>Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hägele H, Lichtnekert J, Hagemann JH, Rupanagudi KV, Ryu M, Schwarzenberger C, Hohenstein B, Hugo C, Uhl B, Reichel CA, Krombach F, Monestier M, Liapis H, Moreth K, Schaefer L, Anders HJ (2012) Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 23:1375–1388</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402284</ArticleId><ArticleId IdType="pubmed">22677551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai C, Kotani H, Miyao M, Ishida T, Jemail L, Abiru H, Tamaki K (2016) Circulating extracellular histones are clinically relevant mediators of multiple organ injury. Am J Pathol 186:829–843</Citation><ArticleIdList><ArticleId IdType="pubmed">26878212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, Brinkmann V, von Bernuth H, Zychlinsky A (2017) Diverse stimuli engage different neutrophil extracellular trap pathways. Elife 6:e24437</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496738</ArticleId><ArticleId IdType="pubmed">28574339</ArticleId></ArticleIdList></Reference><Reference><Citation>Masucci MT, Minopoli M, Del Vecchio S, Carriero MV (2020) The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis. Front Immunol 11:1749</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524869</ArticleId><ArticleId IdType="pubmed">33042107</ArticleId></ArticleIdList></Reference><Reference><Citation>Block H, Rossaint J, Zarbock A (2022) The fatal circle of NETs and NET-associated DAMPs contributing to organ dysfunction. Cells 11:1919</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9222025</ArticleId><ArticleId IdType="pubmed">35741047</ArticleId></ArticleIdList></Reference><Reference><Citation>Juha M, Molnár A, Jakus Z, Ledó N (2023) NETosis: an emerging therapeutic target in renal diseases. Front Immunol 14:1253667</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10514582</ArticleId><ArticleId IdType="pubmed">37744367</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18:134–147</Citation><ArticleIdList><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Thålin C, Hisada Y, Lundström S, Mackman N, Wallén H (2019) Neutrophil extracellular traps. Arterioscler Thromb Vasc Biol 39:1724–1738</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6703916</ArticleId><ArticleId IdType="pubmed">31315434</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V, Papayannopoulos V, Zychlinsky A (2011) Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117:953–959</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035083</ArticleId><ArticleId IdType="pubmed">20974672</ArticleId></ArticleIdList></Reference><Reference><Citation>Scieszka D, Lin Y-H, Li W, Choudhury S, Yu Y, Freire M (2020) Netome: the molecular characterization of neutrophil extracellular traps (NETs). bioRxiv: 2020.2005.2018.102772</Citation></Reference><Reference><Citation>Donkel SJ, Wolters FJ, Ikram MA, de Maat MPM (2021) Circulating Myeloperoxidase (MPO)-DNA complexes as marker for Neutrophil Extracellular Traps (NETs) levels and the association with cardiovascular risk factors in the general population. PLoS ONE. 10.1371/journal.pone.0253698</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357174</ArticleId><ArticleId IdType="pubmed">34379628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair C, Weber A, Barnes BJ, Egeblad M, Woods RJ, Kanthi Y, Knight JS (2020) Neutrophil extracellular traps in COVID-19. JCI Insight 5:e138999</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne H-J, Brinkmann V, Jenne DE (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623–625</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2760083</ArticleId><ArticleId IdType="pubmed">19448636</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, He X-Y, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, Cody MJ, Manne BK, Portier I, Harris ES, Petrey AC, Beswick EJ, Caulin AF, Iovino A, Abegglen LM, Weyrich AS, Rondina MT, Egeblad M, Schiffman JD, Yost CC (2020) Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136:1169–1179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams ST, Morton B, Alhamdi Y, Alsabani M, Lane S, Welters ID, Wang G, Toh C-H (2019) A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients. Am J Respir Crit Care Med 200:869–880</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6812439</ArticleId><ArticleId IdType="pubmed">31162936</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191:677–691</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3003309</ArticleId><ArticleId IdType="pubmed">20974816</ArticleId></ArticleIdList></Reference><Reference><Citation>Celec P, Vlková B, Lauková L, Bábíčková J, Boor P (2018) Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases. Expert Rev Mol Med 20:e1</Citation><ArticleIdList><ArticleId IdType="pubmed">29343314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper DJ, Plewes K, Grigg MJ, Patel A, Rajahram GS, William T, Hiemstra TF, Wang Z, Barber BE, Anstey NM (2021) An evaluation of commonly used surrogate baseline creatinine values to classify AKI during acute infection. Kidney Int Rep 6:645–656</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7938202</ArticleId><ArticleId IdType="pubmed">33732979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersema R, Jukarainen S, Eck RJ, Kaufmann T, Koeze J, Keus F, Pettilä V, van der Horst ICC, Vaara ST (2020) Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study. Crit Care 24:164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175574</ArticleId><ArticleId IdType="pubmed">32316994</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang KW, Toh QC, Teo BW (2015) Normalisation of urinary biomarkers to creatinine for clinical practice and research—when and why. Singap Med J 56:7–10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4325562</ArticleId><ArticleId IdType="pubmed">25640093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralib AM, Pickering JW, Shaw GM, Devarajan P, Edelstein CL, Bonventre JV, Endre ZH (2012) Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23:322–333</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3269182</ArticleId><ArticleId IdType="pubmed">22095948</ArticleId></ArticleIdList></Reference><Reference><Citation>Frithiof R, Soehnlein O, Eriksson S, Fenhammar J, Hjelmqvist H, Lindbom L, Rundgren M (2011) The effects of isoflurane anesthesia and mechanical ventilation on renal function during endotoxemia. Acta Anaesthesiol Scand 55:401–410</Citation><ArticleIdList><ArticleId IdType="pubmed">21391922</ArticleId></ArticleIdList></Reference><Reference><Citation>Soehnlein O, Eriksson S, Hjelmqvist H, Andersson A, Mörgelin M, Lindbom L, Rundgren M, Frithiof R (2010) Anesthesia aggravates lung damage and precipitates hypotension in endotoxemic sheep. Shock 34:412–419</Citation><ArticleIdList><ArticleId IdType="pubmed">20844413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N, Haggstrom L, Sohrabipour S, Dwivedi DJ, Liaw PC (2022) Investigations of the effectiveness of heparin variants as inhibitors of histones. J Thromb Haemost 20:1485–1495</Citation><ArticleIdList><ArticleId IdType="pubmed">35313081</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>